Impetigo

@article{Johnson2020Impetigo,
  title={Impetigo},
  author={Melinda K Johnson},
  journal={Advanced Emergency Nursing Journal},
  year={2020},
  volume={42},
  pages={262 - 269}
}
Impetigo is a common superficial bacterial infection of the skin, with a global disease burden of greater than 140 million. Children are more affected than adults and incidence decreases with age. Principal pathogens implicated include Staphylococcus aureus and Streptococcus pyogenes. There are two common variants of impetigo: nonbullous (70%) and bullous (30%). Nonbullous impetigo is caused by S. aureus and S. pyogenes whereas bullous impetigo is caused by S. aureus. The classic appearance of… 

References

SHOWING 1-10 OF 11 REFERENCES

Impetigo: diagnosis and treatment.

Treatment for impetigo primarily affects the skin or secondarily infects insect bites, eczema, or herpetic lesions, and natural therapies such as tea tree oil; olive, garlic, and coconut oils; and Manuka honey have been anecdotally successful, but lack sufficient evidence to recommend or dismiss them as treatment options.

Interventions for impetigo.

There is good evidence that topical mupirocin and topical fusidic acid are equally, or more effective than oral treatment for people with limited disease, but it is unclear if oral antibiotics are superior to topical antibiotics forPeople with extensive impetigo.

Bacterial Resistance and Impetigo Treatment Trends: A Review

Physicians should be aware of local resistance patterns in impetigo to help guide therapy and use of topical disinfectants to decrease colonization is an important adjunctive measure.

Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America.

  • D. StevensA. Bisno J. Wade
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2014
This guideline addresses the wide array of SSTIs that occur in this population and emphasizes the importance of clinical skills in promptly diagnosing SSTI, identifying the pathogen, and administering effective treatments in a timely fashion.

The staphylococcal scalded skin syndrome.

  • E. Dowsett
  • Medicine
    The Journal of hospital infection
  • 1984

The Global Epidemiology of Impetigo: A Systematic Review of the Population Prevalence of Impetigo and Pyoderma

The global population of children suffering from impetigo at any one time is estimated to be in excess of 162 million, predominantly in tropical, resource-poor contexts.

Ozenoxacin, a New Effective and Safe Topical Treatment for Impetigo in Children and Adolescents

This combined analysis supports the efficacy and safety of ozenoxacin administered twice daily for 5 days for treatment of non-bullous impetigo in children aged 6 months to <18 years.

Poststreptococcal glomerulonephritis.

Although it is generally agreed upon, on the basis of clinical observations, that recovery from acute glomerulonephritis generally occurs in children, confusion still exists concerning the precise frequency with which chronicity may happen in this disease.

Efficacy and Safety of Ozenoxacin Cream for Treatment of Adult and Pediatric Patients With Impetigo: A Randomized Clinical Trial

Topical ozenoxacin is effective and well tolerated in the treatment of impetigo in patients 2 months and older; this effect is demonstrated by rapid onset of response and superior clinical and microbiological response compared with placebo.

The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions.

Using more data than has been used previously, the burden due to skin disease prevention and treatment is enormous in both high- and low-income countries.